Fort Technology Inc. (FRTT) is a Burnaby, British Columbia-based e-commerce consumer products company that develops and sells pest control and remedial repair brands — including Roshield, Entopest, Rempro and BirdGo — mostly through Amazon marketplaces in the United Kingdom and continental Europe. It listed on Nasdaq in June 2026 and is majority-owned by Nexera Technologies (NEXR).
On Thursday, the stock traded at $0.5782, down 19.44% from the prior close of $0.7180, putting the shares back below the 50-day moving average. The decline followed an extraordinary two-session run: FRTT jumped 77.74% on Tuesday to $0.6754 on record volume, then added 6.31% on Wednesday. There was no fresh press release, filing, or analyst action behind Thursday's pullback — the move is a reversal of that speculative spike.
The rally began with genuine fundamental news. On Tuesday, Fort reported nine-month revenue of $11.981 million, up 49% year over year and the highest in company history, with gross profit of $2.092 million, up 202%, and gross margin expanding to 17.5% from 8.6%. Third-quarter revenue rose 48% to $4.625 million, and the quarterly operating loss narrowed to $0.491 million from $0.670 million.
For a company with a market capitalization near $9 million, that is material. But the 77.7% response — on turnover exceeding 400 million shares, roughly 27 times the entire share count — was far larger than the results alone could justify. Thursday's action is consistent with short-term capital exiting after the re-rating, a pattern typical of low-float micro-caps where momentum buyers dominate the order book.
The structural backdrop matters. Fort has entered securities purchase agreements with two institutional investors for unsecured convertible promissory notes of up to $20 million, issued at a 10% original issue discount, bearing 8% interest and maturing in 28 months. Crucially, the notes convert at the lower of a fixed price and 88% of the lowest daily VWAP during the 20 trading days preceding conversion, and each tranche carries warrants plus an initial $1 million in commitment shares.
Terms of that kind give holders a built-in discount to market and an incentive to convert and resell, generating a steady supply of new stock into any rally. With only about 15.2 million shares outstanding and roughly 4.4 million in the float, that supply is heavy relative to the tradable base. A Nasdaq minimum-bid-price deficiency notice adds a further compliance overhang while the stock trades under $1.
Volume on Thursday was modest rather than heavy — under a million shares by midday against a 20-day average near 22 million that is itself distorted by Tuesday's 413 million-share session. That combination of a sharp price decline on light volume points to thin liquidity and a lack of committed buyers rather than aggressive institutional selling.
No peer group or sector catalyst explains the move. The decline was confined to FRTT and reflects company-specific positioning. The stock also lost the $0.70 area that had acted as the 50-day reference, and it remains far below its 52-week high of $4.09 while holding a gain of roughly 52% from Monday's $0.380 close. The company's November 6 delisting from the TSX Venture Exchange has concentrated trading on a single U.S. venue, amplifying price swings.
The scale runs from 0, meaning no meaningful news and a move that is normal for the stock, to 100, meaning transformative news and an extreme, rare price move. FRTT scores 38 out of 100.
The verified news is moderate: record nine-month revenue and gross profit are meaningful for a company this small, and the $20 million convertible facility is a material development, but neither is transformative and neither was released Thursday. The price move was unusual — about 3.8 times the stock's 5.2% average absolute daily change over the past 60 sessions, with only one larger swing in that window. With volume below average, the two components combine into a mid-range score.
Fourth-quarter and full-year results will be the next fundamental checkpoint, and investors will focus on whether the 41% growth in UK revenue and the improved Amazon commission terms carry into the holiday quarter. Progress toward the remaining Nexera milestones — at least $8 million of qualifying financing and $15 million in annual revenue by December 31, 2028 — is another marker to track, since achievement would trigger additional contingent share issuance to the parent.
The key risks are dilution from quarterly note tranches, dependence on a single sales channel and a concentrated European customer base, a cash balance of just $1.6 million, and the possibility that Nasdaq regains compliance pressure if the bid price stays depressed. With a float this small, further double-digit swings in either direction remain plausible.
Tickeron's Trending AI Robots page curates the strongest-performing automated strategies under current market conditions from a library of hundreds of AI trading bots covering thousands of tickers. Bots differ widely by strategy logic, timeframe, performance metrics, and the symbols they trade, so the featured list changes as market conditions shift. Reviewing the trending lineup is a practical way to see which approaches are working right now — explore the page and compare the bots for yourself.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 13 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Momentum Indicator moved above the 0 level on November 17, 2026. You may want to consider a long position or call options on FRTT as a result. In 5 of 8 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 62%.
The Moving Average Convergence Divergence (MACD) for FRTT just turned positive on November 17, 2026. Looking at past instances where FRTT's MACD turned positive, the stock continued to rise in 1 of 1 cases over the following month. The odds of a continued upward trend are 90%.
Following a +88.95% 3-day Advance, the price is estimated to grow further. Considering data from situations where FRTT advanced for three days, in 6 of 9 cases, the price rose further within the following month. The odds of a continued upward trend are 67%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FRTT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
FRTT broke above its upper Bollinger Band on November 17, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for FRTT entered a downward trend on November 17, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 36 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.343) is normal, around the industry mean (21.731). P/E Ratio (-0.948) is within average values for comparable stocks, (16.288). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.518). Dividend Yield (0.000) settles around the average of (0.032) among similar stocks. P/S Ratio (1.030) is also within normal values, averaging (1.902).
The Tickeron Price Growth Rating for this company is 45 (best 1 - 100 worst), indicating steady price growth. FRTT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FRTT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 87, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry HouseholdPersonalCare